New patent expiration for Abbvie drug ACUVAIL
Annual Drug Patent Expirations for ACUVAIL Acuvail is a drug marketed by Abbvie and is included in one NDA. It […]
Patent Expiration
New patent expiration for Mayne Pharma drug RHOFADE
Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA.
New patent expiration for Mayne Pharma drug RHOFADE Read Post »
New patent expiration for Kowa Co drug LIVALO
Annual Drug Patent Expirations for LIVALO Livalo is a drug marketed by Kowa Co and is included in one NDA.
New patent expiration for Endo Pharms drug NASCOBAL
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is
New patent expiration for Endo Pharms drug NASCOBAL Read Post »
New patent expiration for Janssen Pharms drug INVOKAMET
Annual Drug Patent Expirations for INVOKAMET Invokamet is a drug marketed by Janssen Pharms and is included in two NDAs.
New patent expiration for Janssen Pharms drug INVOKAMET Read Post »
New patent expiration for Helsinn Hlthcare drug ALOXI
Annual Drug Patent Expirations for ALOXI Aloxi is a drug marketed by Helsinn Hlthcare and is included in two NDAs.
New patent expiration for Helsinn Hlthcare drug ALOXI Read Post »
New patent expiration for Janssen Pharms drug INVOKAMET XR
Annual Drug Patent Expirations for INVOKAMET+XR Invokamet Xr is a drug marketed by Janssen Pharms and is included in one
New patent expiration for Janssen Pharms drug INVOKAMET XR Read Post »
Drug Patent Expirations for the Week of July 28, 2024
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of July 28, 2024 Read Post »
Drug Patent Expirations for the Week of July 28, 2024
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of July 28, 2024 Read Post »
